0000950170-24-069549.txt : 20240605 0000950170-24-069549.hdr.sgml : 20240605 20240605200003 ACCESSION NUMBER: 0000950170-24-069549 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman Fred CENTRAL INDEX KEY: 0001985154 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 241023567 MAIL ADDRESS: STREET 1: C/O COYA THERAPEUTICS, INC. STREET 2: 5850 SAN FELIPE ST., SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml 4 X0508 4 2024-06-03 0001835022 Coya Therapeutics, Inc. COYA 0001985154 Grossman Fred 5850 SAN FELIPE ST., SUITE 500 HOUSTON TX 77057 false true false false Chief Medical Officer false Stock Option (right to buy) 8.15 2024-06-03 4 A false 70596 0 A 2034-06-03 Common Stock 70596 70596 D Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024. /s/ David Snyder, Attorney-in-Fact 2024-06-05